| Opportunity ID: |
330147 |
| Opportunity Number: |
NOT-CA-21-016 |
| Opportunity Title: |
Notice of Intent to Publish a Funding Opportunity Announcement for Cellular Cancer Biology Imaging Research (CCBIR) Program (U54 Clinical Trial Not Allowed) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.396 |
| Eligible Applicants: |
State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
|
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
Dec 01, 2020 |
| Last Updated Date: |
Dec 01, 2020 |
| Estimated Synopsis Post Date: |
Dec 10, 2020 |
| Fiscal Year: |
2022 |
| Award Ceiling: |
$1,250,000 |
| Award Floor: |
|
| Estimated Total Program Funding: |
$9,000,000 |
| Expected Number of Awards: |
4 |
| Description: |
The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to invite applications for Cellular Cancer Biology Imaging Research (CCBIR) Centers (U54 activity code). The Centers will develop and test enabling imaging technologies at the cellular and organ scales driven by specific fundamental questions in cancer biology. The overall purpose of the CCBIR initiative is to facilitate innovation in advanced imaging technologies that could be applied to fundamental basic and pre-clinical research problems in cancer biology. CCBIR Centers are structured to operate collaboratively between technology developers and cancer biologists at the forefront of their respective fields. CCBIR Centers will increase in experimental sophistication over time to ultimately produce an interoperable suite of state-of-the-art imaging technologies with transformative potential to study the cancer biology process(es) that defines the Center. The cadre of CCBIR Centers will form a consortium that will be expected to engage with the broader cancer research community. |
| Version: |
1 |
